[Br:1][C:2]1[CH:3]=[CH:4][C:5](/[CH:8]=[CH:9]/[CH:10]=[O:11])=[N:6][CH:7]=1.[CH3:12][C:13]1([CH3:21])[CH2:20][C:18](=O)[CH2:17][C:15](=[O:16])[CH2:14]1.[NH2:22][C:23]1[NH:27][N:26]=[CH:25][CH:24]=1.C1C([NH:31]C(C)=O)C1>>[Br:1][C:2]1[CH:3]=[CH:4][C:5](/[CH:8]=[CH:9]/[CH:10]2[C:17]3[C:15](=[O:16])[CH2:14][C:13]([CH3:12])([CH3:21])[CH2:20][C:18]=3[NH:22][C:23]3[NH:27][N:26]=[CH:25][C:24]2=3)=[N:6][CH:7]=1.[CH2:5]1[CH:8]([CH2:9][C:10]([NH2:31])=[O:11])[CH2:4]1The title compound is prepared analogously to procedure A from 150 mg of (E)-3-(5-bromopyridin-2-yl)propenal, 100 mg of dimedone and 127 mg of 5-amino-1H-pyrazole-3-cyclopropyl methylcarboxamide.